Clinical Trial Update: A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a pediatric-inspired regimen with reduced myelosuppressive drugs for adults age 18-60 with newly diagnosed Philadelphia-n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING